Relationship Between Breathing and Attention in Children With Ondine Syndrome
OndineCo
2 other identifiers
observational
20
1 country
1
Brief Summary
Congenital central hypoventilation syndrome (CCHS) is a rare disorder of autonomic and respiratory regulation that alters oxygen delivery to the brain. CCHS patients are at risk for broad neurocognitive deficits. Patients retain ventilatory activity when awake through a respiratory-related cortical network but the need to mobilise cortical resources to breathe lead to breathing-cognition interferences during cognitive tasks. The purpose of this study is to assess the relationship between breathing pattern and attention in CCHS children
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 29, 2024
CompletedFirst Submitted
Initial submission to the registry
March 22, 2024
CompletedFirst Posted
Study publicly available on registry
March 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedMarch 29, 2024
March 1, 2024
1 year
March 22, 2024
March 22, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Wechsler scale
Neuropsychological assessement
12 months
Nepsy II test
Neuropsychological assessement
12 months
Interventions
neuropsychological tests used usually in clinical practice (TEA-ch, NEPSY, BRIEF) and research (Conners 3, K-CPT II or CPT III, Flankers Task)
Eligibility Criteria
Ondine Syndrome, children with CCHS
You may qualify if:
- children with CCHS (Ondine Syndrome) and IQ \> 70, age from 6 to 16 years old, french speaking, informed consent signed by both parents and oral agreement in principle given by the subject.
You may not qualify if:
- IQ \< 70
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Robert Debre Hospital
Paris, 75019, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne-Claude TABET, MD, PhD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2024
First Posted
March 29, 2024
Study Start
February 29, 2024
Primary Completion
March 1, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
March 29, 2024
Record last verified: 2024-03